VisionPoint Advisory Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$400K Sell
6,855
-238
-3% -$13.3K 0.06% 283
2026
Q2
$386K Buy
7,093
+71
+1% +$3.46K 0.06% 304
2026
Q1
$301K Sell
7,022
-401
-5% -$17.2K 0.06% 334
2025
Q4
$325K Buy
7,423
+1,685
+29% +$69.7K 0.06% 286
2025
Q3
$237K Buy
+5,738
New +$231K 0.05% 350

Other funds holding EXEL

VisionPoint Advisory Group's EXEL Position: Q3 2026 in Review

VisionPoint Advisory Group reduced its Exelixis (EXEL) stake by 3.4% in Q3 2026, selling an estimated $13.3K and leaving 6,855 shares worth $400K. The position accounts for 0.06% of the portfolio, ranked #283.

VisionPoint Advisory Group first reported a position in EXEL in Q3 2025 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • VisionPoint Advisory Group held 6,855 shares of Exelixis worth $400K as of Q3 2026.
  • VisionPoint Advisory Group sold 238 Exelixis shares in Q3 2026, an estimated $13.3K.
  • Exelixis made up 0.06% of VisionPoint Advisory Group's portfolio in Q3 2026, its #283 holding.
  • VisionPoint Advisory Group first reported a position in Exelixis in Q3 2025 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.